Molecular imaging and targeted therapy of the aggressive phenotype: development of uPAR theranostics for cancer patients

Project Information

uPET

Grant agreement ID: 670261

DOI

10.3030/670261

Project closed

EC signature date 7 September 2015

Start date 1 October 2015

End date 31 March 2021

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost

€ 2 072 000,00

EU contribution

€ 2 072 000,00

Coordinated by

REGION HOVEDSTADEN
Denmark

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (9)

[68Ga]Ga-NODAGA-E[(cRGDyK)]2 PET and hyperpolarized [1-13C] pyruvate MRSI (hyperPET) in canine cancer patients: simultaneous imaging of angiogenesis and the Warburg effect

Author(s): Andreas Clemmensen, Adam E Hansen, Pernille Holst, Christina Schøier, Sissel Bisgaard, Helle H Johannesen, Jan Henrik Ardenkjær-Larsen, Annemarie T Kristensen, Andreas Kjaer
Published in: European Journal of Nuclear Medicine and Molecular Imaging, Issue 48/2, 2021, Page(s) 395-405, ISSN 1619-7070
Publisher: Springer Verlag
DOI: 10.1007/s00259-020-04881-0

Urokinase-Type Plasminogen Activator Receptor (uPAR) PET/MRI of Prostate Cancer for Noninvasive Evaluation of Aggressiveness: Comparison with Gleason Score in a Prospective Phase 2 Clinical Trial

Author(s): Marie Øbro Fosbøl, Sorel Kurbegovic, Helle Hjorth Johannesen, Martin Andreas Røder, Adam Espe Hansen, Jann Mortensen, Annika Loft, Peter Meidahl Petersen, Jacob Madsen, Klaus Brasso, Andreas Kjaer
Published in: Journal of Nuclear Medicine, Issue 62/3, 2021, Page(s) 354-359, ISSN 0161-5505
Publisher: Kexue Chubaneshe/Science Press
DOI: 10.2967/jnumed.120.248120

Improved surgical resection of metastatic pancreatic cancer using uPAR targeted in vivo fluorescent guidance: comparison with traditional white light surgery

Author(s): Karina Juhl, Anders Christensen, Niclas Rubek, Kirstine Kim Schmidt Karnov, Christian von Buchwald, Andreas Kjaer
Published in: Oncotarget, Issue 10/59, 2019, Page(s) 6308-6316, ISSN 1949-2553
Publisher: Impact Journals
DOI: 10.18632/oncotarget.27220

Combined hyperpolarized 13 C-pyruvate MRS and 18 F-FDG PET (hyperPET) estimates of glycolysis in canine cancer patients

Author(s): Adam E. Hansen, Henrik Gutte, Pernille Holst, Helle H. Johannesen, Sofie Rahbek, Andreas E. Clemmensen, Majbritt M.E. Larsen, Christina Schøier, Jan Ardenkjaer-Larsen, Thomas L. Klausen, Annemarie T. Kristensen, Andreas Kjaer
Published in: European Journal of Radiology, Issue 103, 2018, Page(s) 6-12, ISSN 0720-048X
Publisher: Elsevier BV
DOI: 10.1016/j.ejrad.2018.02.028

Molecular Targeted NIR-II Probe for Image-Guided Brain Tumor Surgery

Author(s): Sorel Kurbegovic, Karina Juhl, Hao Chen, Chunrong Qu, Bingbing Ding, Julie Maja Leth, Krzysztof Tadeusz Drzewiecki, Andreas Kjaer, Zhen Cheng
Published in: Bioconjugate Chemistry, Issue 29/11, 2018, Page(s) 3833-3840, ISSN 1043-1802
Publisher: American Chemical Society
DOI: 10.1021/acs.bioconjchem.8b00669

uPAR-targeted optical near-infrared (NIR) fluorescence imaging and PET for image-guided surgery in head and neck cancer: proof-of-concept in orthotopic xenograft model

Author(s): Christensen A, Juhl K, Persson M, Charabi BW, Mortensen J, Kiss K, Lelkaitis G, Rubek N, von Buchwald C, Kjær A
Published in: Oncotarget, 2017, ISSN 1949-2553
Publisher: Impact Journals
DOI: 10.18632/oncotarget.14282

Simultaneous PET/MRI with 13C magnetic resonance spectroscopic imaging (hyperPET): phantom-based evaluation of PET quantification

Author(s): Adam E. Hansen, Flemming L. Andersen, Sarah T. Henriksen, Alexandre Vignaud, Jan H. Ardenkjaer-Larsen, Liselotte Højgaard, Andreas Kjaer, Thomas L. Klausen
Published in: EJNMMI Physics, Issue 3/1, 2016, Page(s) 7 (13 pages), ISSN 2197-7364
Publisher: Springer Nature
DOI: 10.1186/s40658-016-0143-6

Improved positron emission tomography imaging of glioblastoma cancer using novel 68Ga-labeled peptides targeting the urokinase-type plasminogen activator receptor (uPAR)

Author(s): Loft MD, Sun Y, Liu C, Christensen C, Huang D, Kjaer A, Cheng Z
Published in: Amino Acids, Issue 49(6), 2017, Page(s) 1089-1100, ISSN 1438-2199
Publisher: Springer Vienna
DOI: 10.1007/s00726-017-2407-4

Safety, Dosimetry, and Tumor Detection Ability of 68Ga-NOTA-AE105: First-in-Human Study of a Novel Radioligand for uPAR PET Imaging

Author(s): Skovgaard D, Persson M, Brandt-Larsen M, Christensen C, Madsen J, Klausen TL, Holm S, Andersen FL, Loft A, Berthelsen AK, Pappot H, Brasso K, Kroman N, Højgaard L, Kjaer A
Published in: J Nucl Med, Issue 58(3), 2017, Page(s) 379-386, ISSN 2159-662X
Publisher: Society of Nuclear Medicine and Molecular Imaging
DOI: 10.2967/jnumed.116.178970